News | March 10, 2026
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
The newly certified kits are designed for early detection and large-scale screening programs
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
PMDA is regarded among the most stringent regulatory bodies globally
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
The goal is to better support drug developers as programs move from laboratory research into clinical trials
Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
Subscribe To Our Newsletter & Stay Updated
